nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—CYP3A4—Disulfiram—alcohol dependence	0.162	0.584	CbGbCtD
Pimecrolimus—CYP3A4—Citalopram—alcohol dependence	0.115	0.416	CbGbCtD
Pimecrolimus—Pharyngitis streptococcal—Naltrexone—alcohol dependence	0.0263	0.0535	CcSEcCtD
Pimecrolimus—Impetigo—Citalopram—alcohol dependence	0.021	0.0427	CcSEcCtD
Pimecrolimus—Varicella—Citalopram—alcohol dependence	0.0179	0.0364	CcSEcCtD
Pimecrolimus—Viral upper respiratory tract infection—Citalopram—alcohol dependence	0.0179	0.0364	CcSEcCtD
Pimecrolimus—Pharyngitis streptococcal—Citalopram—alcohol dependence	0.0167	0.0339	CcSEcCtD
Pimecrolimus—Staphylococcal infection—Citalopram—alcohol dependence	0.014	0.0284	CcSEcCtD
Pimecrolimus—Laceration—Citalopram—alcohol dependence	0.0115	0.0235	CcSEcCtD
Pimecrolimus—Tonsillitis—Citalopram—alcohol dependence	0.00958	0.0195	CcSEcCtD
Pimecrolimus—Acute bronchitis—Citalopram—alcohol dependence	0.00927	0.0189	CcSEcCtD
Pimecrolimus—Skin infection—Citalopram—alcohol dependence	0.00801	0.0163	CcSEcCtD
Pimecrolimus—Tracheobronchitis—Citalopram—alcohol dependence	0.00801	0.0163	CcSEcCtD
Pimecrolimus—Eye infection—Citalopram—alcohol dependence	0.00781	0.0159	CcSEcCtD
Pimecrolimus—MTOR—brainstem—alcohol dependence	0.00771	0.053	CbGeAlD
Pimecrolimus—Sinus congestion—Naltrexone—alcohol dependence	0.00768	0.0156	CcSEcCtD
Pimecrolimus—Alcohol intolerance—Citalopram—alcohol dependence	0.00761	0.0155	CcSEcCtD
Pimecrolimus—MTOR—forebrain—alcohol dependence	0.00744	0.0511	CbGeAlD
Pimecrolimus—Skin papilloma—Citalopram—alcohol dependence	0.00743	0.0151	CcSEcCtD
Pimecrolimus—FKBP1A—Alpha-synuclein signaling—MAOB—alcohol dependence	0.00695	0.0807	CbGpPWpGaD
Pimecrolimus—Loose stools—Naltrexone—alcohol dependence	0.0069	0.014	CcSEcCtD
Pimecrolimus—FKBP1A—forebrain—alcohol dependence	0.00669	0.046	CbGeAlD
Pimecrolimus—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00632	0.0733	CbGpPWpGaD
Pimecrolimus—MTOR—cardiovascular system—alcohol dependence	0.00629	0.0432	CbGeAlD
Pimecrolimus—Toothache—Naltrexone—alcohol dependence	0.00628	0.0128	CcSEcCtD
Pimecrolimus—FKBP1A—adrenal cortex—alcohol dependence	0.0062	0.0426	CbGeAlD
Pimecrolimus—MTOR—pancreas—alcohol dependence	0.00611	0.042	CbGeAlD
Pimecrolimus—MTOR—gonad—alcohol dependence	0.00571	0.0392	CbGeAlD
Pimecrolimus—Ear infection—Citalopram—alcohol dependence	0.00569	0.0116	CcSEcCtD
Pimecrolimus—FKBP1A—cardiovascular system—alcohol dependence	0.00566	0.0389	CbGeAlD
Pimecrolimus—FKBP1A—pancreas—alcohol dependence	0.0055	0.0378	CbGeAlD
Pimecrolimus—Throat sore—Naltrexone—alcohol dependence	0.0053	0.0108	CcSEcCtD
Pimecrolimus—Oropharyngeal discomfort—Naltrexone—alcohol dependence	0.00525	0.0107	CcSEcCtD
Pimecrolimus—Bacterial infection—Citalopram—alcohol dependence	0.00524	0.0107	CcSEcCtD
Pimecrolimus—MTOR—digestive system—alcohol dependence	0.00522	0.0359	CbGeAlD
Pimecrolimus—FKBP1A—gonad—alcohol dependence	0.00513	0.0353	CbGeAlD
Pimecrolimus—MTOR—blood—alcohol dependence	0.00497	0.0342	CbGeAlD
Pimecrolimus—Furuncle—Citalopram—alcohol dependence	0.00493	0.01	CcSEcCtD
Pimecrolimus—Sinus congestion—Citalopram—alcohol dependence	0.00486	0.00989	CcSEcCtD
Pimecrolimus—Rhinorrhoea—Naltrexone—alcohol dependence	0.00471	0.00959	CcSEcCtD
Pimecrolimus—FKBP1A—digestive system—alcohol dependence	0.0047	0.0323	CbGeAlD
Pimecrolimus—FKBP1A—Alpha-synuclein signaling—SLC6A3—alcohol dependence	0.00461	0.0535	CbGpPWpGaD
Pimecrolimus—FKBP1A—blood—alcohol dependence	0.00447	0.0308	CbGeAlD
Pimecrolimus—FKBP1A—midbrain—alcohol dependence	0.00442	0.0304	CbGeAlD
Pimecrolimus—MTOR—endocrine gland—alcohol dependence	0.00431	0.0297	CbGeAlD
Pimecrolimus—Oropharyngeal pain—Naltrexone—alcohol dependence	0.0042	0.00854	CcSEcCtD
Pimecrolimus—MTOR—testis—alcohol dependence	0.00411	0.0283	CbGeAlD
Pimecrolimus—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00404	0.047	CbGpPWpGaD
Pimecrolimus—MTOR—nervous system—alcohol dependence	0.00404	0.0278	CbGeAlD
Pimecrolimus—Toothache—Citalopram—alcohol dependence	0.00398	0.00809	CcSEcCtD
Pimecrolimus—MTOR—liver—alcohol dependence	0.00389	0.0267	CbGeAlD
Pimecrolimus—MTOR—central nervous system—alcohol dependence	0.00389	0.0267	CbGeAlD
Pimecrolimus—FKBP1A—endocrine gland—alcohol dependence	0.00388	0.0267	CbGeAlD
Pimecrolimus—Folliculitis—Citalopram—alcohol dependence	0.00385	0.00783	CcSEcCtD
Pimecrolimus—MTOR—cerebellum—alcohol dependence	0.0038	0.0261	CbGeAlD
Pimecrolimus—FKBP1A—testis—alcohol dependence	0.0037	0.0254	CbGeAlD
Pimecrolimus—FKBP1A—nervous system—alcohol dependence	0.00363	0.025	CbGeAlD
Pimecrolimus—FKBP1A—liver—alcohol dependence	0.0035	0.024	CbGeAlD
Pimecrolimus—FKBP1A—central nervous system—alcohol dependence	0.0035	0.024	CbGeAlD
Pimecrolimus—FKBP1A—cerebellum—alcohol dependence	0.00342	0.0235	CbGeAlD
Pimecrolimus—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00335	0.0389	CbGpPWpGaD
Pimecrolimus—Gastroenteritis—Acamprosate—alcohol dependence	0.00331	0.00672	CcSEcCtD
Pimecrolimus—Swelling—Naltrexone—alcohol dependence	0.00314	0.00639	CcSEcCtD
Pimecrolimus—Gastroenteritis—Naltrexone—alcohol dependence	0.00313	0.00636	CcSEcCtD
Pimecrolimus—Otitis media—Citalopram—alcohol dependence	0.00311	0.00632	CcSEcCtD
Pimecrolimus—Dermatitis exfoliative—Acamprosate—alcohol dependence	0.00311	0.00631	CcSEcCtD
Pimecrolimus—MTOR—brain—alcohol dependence	0.00309	0.0212	CbGeAlD
Pimecrolimus—Nasal congestion—Naltrexone—alcohol dependence	0.00304	0.00619	CcSEcCtD
Pimecrolimus—Rhinorrhoea—Citalopram—alcohol dependence	0.00299	0.00607	CcSEcCtD
Pimecrolimus—Acne—Citalopram—alcohol dependence	0.00288	0.00585	CcSEcCtD
Pimecrolimus—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00285	0.0331	CbGpPWpGaD
Pimecrolimus—Eye irritation—Citalopram—alcohol dependence	0.00283	0.00576	CcSEcCtD
Pimecrolimus—Face oedema—Acamprosate—alcohol dependence	0.00283	0.00575	CcSEcCtD
Pimecrolimus—FKBP1A—brain—alcohol dependence	0.00278	0.0191	CbGeAlD
Pimecrolimus—Viral infection—Citalopram—alcohol dependence	0.00268	0.00545	CcSEcCtD
Pimecrolimus—Bone disorder—Citalopram—alcohol dependence	0.00268	0.00545	CcSEcCtD
Pimecrolimus—Skin discolouration—Citalopram—alcohol dependence	0.00268	0.00545	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—PDYN—alcohol dependence	0.00268	0.0311	CbGpPWpGaD
Pimecrolimus—Face oedema—Naltrexone—alcohol dependence	0.00268	0.00544	CcSEcCtD
Pimecrolimus—Dysmenorrhoea—Citalopram—alcohol dependence	0.00266	0.00541	CcSEcCtD
Pimecrolimus—Breast disorder—Acamprosate—alcohol dependence	0.00265	0.00538	CcSEcCtD
Pimecrolimus—Herpes simplex—Citalopram—alcohol dependence	0.00263	0.00534	CcSEcCtD
Pimecrolimus—Paraesthesia—Disulfiram—alcohol dependence	0.00263	0.00534	CcSEcCtD
Pimecrolimus—Asthma—Acamprosate—alcohol dependence	0.00253	0.00515	CcSEcCtD
Pimecrolimus—Influenza—Acamprosate—alcohol dependence	0.00253	0.00515	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Naltrexone—alcohol dependence	0.00253	0.00515	CcSEcCtD
Pimecrolimus—Pain—Disulfiram—alcohol dependence	0.0025	0.00508	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Naltrexone—alcohol dependence	0.00248	0.00504	CcSEcCtD
Pimecrolimus—Bronchitis—Acamprosate—alcohol dependence	0.00244	0.00495	CcSEcCtD
Pimecrolimus—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00242	0.0281	CbGpPWpGaD
Pimecrolimus—Influenza—Naltrexone—alcohol dependence	0.0024	0.00487	CcSEcCtD
Pimecrolimus—Wheezing—Citalopram—alcohol dependence	0.00235	0.00478	CcSEcCtD
Pimecrolimus—Influenza like illness—Citalopram—alcohol dependence	0.00235	0.00478	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00231	0.0047	CcSEcCtD
Pimecrolimus—Bronchitis—Naltrexone—alcohol dependence	0.0023	0.00469	CcSEcCtD
Pimecrolimus—Pneumonia—Acamprosate—alcohol dependence	0.00227	0.00462	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00223	0.00453	CcSEcCtD
Pimecrolimus—Pneumonia—Naltrexone—alcohol dependence	0.00215	0.00437	CcSEcCtD
Pimecrolimus—Infestation—Naltrexone—alcohol dependence	0.00214	0.00434	CcSEcCtD
Pimecrolimus—Infestation NOS—Naltrexone—alcohol dependence	0.00214	0.00434	CcSEcCtD
Pimecrolimus—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00213	0.0247	CbGpPWpGaD
Pimecrolimus—Epistaxis—Acamprosate—alcohol dependence	0.00213	0.00433	CcSEcCtD
Pimecrolimus—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00212	0.0247	CbGpPWpGaD
Pimecrolimus—Conjunctivitis—Naltrexone—alcohol dependence	0.00208	0.00422	CcSEcCtD
Pimecrolimus—Ear pain—Citalopram—alcohol dependence	0.00206	0.00419	CcSEcCtD
Pimecrolimus—Rhinitis—Acamprosate—alcohol dependence	0.00203	0.00413	CcSEcCtD
Pimecrolimus—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00202	0.0235	CbGpPWpGaD
Pimecrolimus—MTOR—IL4-mediated signaling events—OPRM1—alcohol dependence	0.00202	0.0235	CbGpPWpGaD
Pimecrolimus—Epistaxis—Naltrexone—alcohol dependence	0.00202	0.0041	CcSEcCtD
Pimecrolimus—Pharyngitis—Acamprosate—alcohol dependence	0.00201	0.00409	CcSEcCtD
Pimecrolimus—Sinusitis—Naltrexone—alcohol dependence	0.002	0.00408	CcSEcCtD
Pimecrolimus—Gastroenteritis—Citalopram—alcohol dependence	0.00198	0.00403	CcSEcCtD
Pimecrolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—CHRM2—alcohol dependence	0.00194	0.0225	CbGpPWpGaD
Pimecrolimus—Nasal congestion—Citalopram—alcohol dependence	0.00193	0.00392	CcSEcCtD
Pimecrolimus—Pharyngitis—Naltrexone—alcohol dependence	0.0019	0.00387	CcSEcCtD
Pimecrolimus—Rash—Disulfiram—alcohol dependence	0.00184	0.00375	CcSEcCtD
Pimecrolimus—Headache—Disulfiram—alcohol dependence	0.00183	0.00372	CcSEcCtD
Pimecrolimus—Immune system disorder—Acamprosate—alcohol dependence	0.00183	0.00372	CcSEcCtD
Pimecrolimus—Eye disorder—Naltrexone—alcohol dependence	0.00179	0.00364	CcSEcCtD
Pimecrolimus—Malnutrition—Acamprosate—alcohol dependence	0.00176	0.00359	CcSEcCtD
Pimecrolimus—Immune system disorder—Naltrexone—alcohol dependence	0.00173	0.00352	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Naltrexone—alcohol dependence	0.00173	0.00351	CcSEcCtD
Pimecrolimus—Back pain—Acamprosate—alcohol dependence	0.00171	0.00347	CcSEcCtD
Pimecrolimus—Face oedema—Citalopram—alcohol dependence	0.0017	0.00345	CcSEcCtD
Pimecrolimus—Malnutrition—Naltrexone—alcohol dependence	0.00167	0.00339	CcSEcCtD
Pimecrolimus—Back pain—Naltrexone—alcohol dependence	0.00162	0.00328	CcSEcCtD
Pimecrolimus—Angioedema—Acamprosate—alcohol dependence	0.00161	0.00328	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Citalopram—alcohol dependence	0.0016	0.00326	CcSEcCtD
Pimecrolimus—Breast disorder—Citalopram—alcohol dependence	0.00159	0.00323	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Citalopram—alcohol dependence	0.00157	0.00319	CcSEcCtD
Pimecrolimus—Cough—Acamprosate—alcohol dependence	0.00154	0.00313	CcSEcCtD
Pimecrolimus—MTOR—ErbB1 downstream signaling—WASF2—alcohol dependence	0.00154	0.0178	CbGpPWpGaD
Pimecrolimus—CYP3A4—digestive system—alcohol dependence	0.00153	0.0105	CbGeAlD
Pimecrolimus—Angioedema—Naltrexone—alcohol dependence	0.00153	0.0031	CcSEcCtD
Pimecrolimus—Asthma—Citalopram—alcohol dependence	0.00152	0.00309	CcSEcCtD
Pimecrolimus—Influenza—Citalopram—alcohol dependence	0.00152	0.00309	CcSEcCtD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—WASF2—alcohol dependence	0.00151	0.0176	CbGpPWpGaD
Pimecrolimus—Arthralgia—Acamprosate—alcohol dependence	0.0015	0.00305	CcSEcCtD
Pimecrolimus—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.0015	0.0174	CbGpPWpGaD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00149	0.00303	CcSEcCtD
Pimecrolimus—CYP3A4—blood—alcohol dependence	0.00146	0.01	CbGeAlD
Pimecrolimus—Bronchitis—Citalopram—alcohol dependence	0.00146	0.00297	CcSEcCtD
Pimecrolimus—Cough—Naltrexone—alcohol dependence	0.00146	0.00296	CcSEcCtD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—WASF1—alcohol dependence	0.00145	0.0169	CbGpPWpGaD
Pimecrolimus—Anaphylactic shock—Acamprosate—alcohol dependence	0.00144	0.00293	CcSEcCtD
Pimecrolimus—Infection—Acamprosate—alcohol dependence	0.00143	0.00291	CcSEcCtD
Pimecrolimus—MTOR—Signaling by VEGF—WASF2—alcohol dependence	0.00143	0.0166	CbGpPWpGaD
Pimecrolimus—Arthralgia—Naltrexone—alcohol dependence	0.00142	0.00289	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00141	0.00287	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00141	0.00287	CcSEcCtD
Pimecrolimus—Skin disorder—Acamprosate—alcohol dependence	0.0014	0.00284	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Citalopram—alcohol dependence	0.00139	0.00282	CcSEcCtD
Pimecrolimus—MTOR—Signaling by VEGF—WASF1—alcohol dependence	0.00137	0.0159	CbGpPWpGaD
Pimecrolimus—Oedema—Naltrexone—alcohol dependence	0.00136	0.00277	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Naltrexone—alcohol dependence	0.00136	0.00277	CcSEcCtD
Pimecrolimus—Pneumonia—Citalopram—alcohol dependence	0.00136	0.00277	CcSEcCtD
Pimecrolimus—Infection—Naltrexone—alcohol dependence	0.00135	0.00275	CcSEcCtD
Pimecrolimus—Infestation—Citalopram—alcohol dependence	0.00135	0.00275	CcSEcCtD
Pimecrolimus—Infestation NOS—Citalopram—alcohol dependence	0.00135	0.00275	CcSEcCtD
Pimecrolimus—Nervous system disorder—Naltrexone—alcohol dependence	0.00134	0.00272	CcSEcCtD
Pimecrolimus—Skin disorder—Naltrexone—alcohol dependence	0.00132	0.00269	CcSEcCtD
Pimecrolimus—Conjunctivitis—Citalopram—alcohol dependence	0.00132	0.00268	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00131	0.00267	CcSEcCtD
Pimecrolimus—Paraesthesia—Acamprosate—alcohol dependence	0.00129	0.00263	CcSEcCtD
Pimecrolimus—Dyspnoea—Acamprosate—alcohol dependence	0.00128	0.00261	CcSEcCtD
Pimecrolimus—Epistaxis—Citalopram—alcohol dependence	0.00128	0.0026	CcSEcCtD
Pimecrolimus—Sinusitis—Citalopram—alcohol dependence	0.00127	0.00258	CcSEcCtD
Pimecrolimus—CYP3A4—endocrine gland—alcohol dependence	0.00127	0.00872	CbGeAlD
Pimecrolimus—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00124	0.00253	CcSEcCtD
Pimecrolimus—MTOR—HSF1-dependent transactivation—EP300—alcohol dependence	0.00124	0.0144	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00124	0.00252	CcSEcCtD
Pimecrolimus—Pain—Acamprosate—alcohol dependence	0.00123	0.0025	CcSEcCtD
Pimecrolimus—Constipation—Acamprosate—alcohol dependence	0.00123	0.0025	CcSEcCtD
Pimecrolimus—Paraesthesia—Naltrexone—alcohol dependence	0.00122	0.00249	CcSEcCtD
Pimecrolimus—Rhinitis—Citalopram—alcohol dependence	0.00122	0.00248	CcSEcCtD
Pimecrolimus—Dyspnoea—Naltrexone—alcohol dependence	0.00121	0.00247	CcSEcCtD
Pimecrolimus—Pharyngitis—Citalopram—alcohol dependence	0.00121	0.00245	CcSEcCtD
Pimecrolimus—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.0012	0.0139	CbGpPWpGaD
Pimecrolimus—CYP3A4—nervous system—alcohol dependence	0.00119	0.00816	CbGeAlD
Pimecrolimus—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00118	0.00239	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00118	0.00239	CcSEcCtD
Pimecrolimus—Constipation—Naltrexone—alcohol dependence	0.00117	0.00237	CcSEcCtD
Pimecrolimus—Pain—Naltrexone—alcohol dependence	0.00117	0.00237	CcSEcCtD
Pimecrolimus—Urticaria—Acamprosate—alcohol dependence	0.00114	0.00233	CcSEcCtD
Pimecrolimus—CYP3A4—liver—alcohol dependence	0.00114	0.00786	CbGeAlD
Pimecrolimus—CYP3A4—central nervous system—alcohol dependence	0.00114	0.00785	CbGeAlD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00114	0.0132	CbGpPWpGaD
Pimecrolimus—Body temperature increased—Acamprosate—alcohol dependence	0.00114	0.00232	CcSEcCtD
Pimecrolimus—Abdominal pain—Acamprosate—alcohol dependence	0.00114	0.00232	CcSEcCtD
Pimecrolimus—Eye disorder—Citalopram—alcohol dependence	0.00114	0.00231	CcSEcCtD
Pimecrolimus—Flushing—Citalopram—alcohol dependence	0.00113	0.00229	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00111	0.00227	CcSEcCtD
Pimecrolimus—Immune system disorder—Citalopram—alcohol dependence	0.0011	0.00223	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Citalopram—alcohol dependence	0.0011	0.00223	CcSEcCtD
Pimecrolimus—Urticaria—Naltrexone—alcohol dependence	0.00108	0.0022	CcSEcCtD
Pimecrolimus—FKBP1A—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—alcohol dependence	0.00108	0.0125	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—EP300—alcohol dependence	0.00108	0.0125	CbGpPWpGaD
Pimecrolimus—Abdominal pain—Naltrexone—alcohol dependence	0.00108	0.00219	CcSEcCtD
Pimecrolimus—Body temperature increased—Naltrexone—alcohol dependence	0.00108	0.00219	CcSEcCtD
Pimecrolimus—Hypersensitivity—Acamprosate—alcohol dependence	0.00106	0.00216	CcSEcCtD
Pimecrolimus—Malnutrition—Citalopram—alcohol dependence	0.00106	0.00215	CcSEcCtD
Pimecrolimus—Erythema—Citalopram—alcohol dependence	0.00106	0.00215	CcSEcCtD
Pimecrolimus—Back pain—Citalopram—alcohol dependence	0.00102	0.00208	CcSEcCtD
Pimecrolimus—Pruritus—Acamprosate—alcohol dependence	0.00102	0.00207	CcSEcCtD
Pimecrolimus—Hypersensitivity—Naltrexone—alcohol dependence	0.001	0.00204	CcSEcCtD
Pimecrolimus—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.001	0.0116	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Acamprosate—alcohol dependence	0.000985	0.002	CcSEcCtD
Pimecrolimus—Angioedema—Citalopram—alcohol dependence	0.000967	0.00197	CcSEcCtD
Pimecrolimus—Pruritus—Naltrexone—alcohol dependence	0.000964	0.00196	CcSEcCtD
Pimecrolimus—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000963	0.0112	CbGpPWpGaD
Pimecrolimus—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000958	0.0111	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000944	0.011	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Naltrexone—alcohol dependence	0.000932	0.0019	CcSEcCtD
Pimecrolimus—Cough—Citalopram—alcohol dependence	0.000923	0.00188	CcSEcCtD
Pimecrolimus—Vomiting—Acamprosate—alcohol dependence	0.000916	0.00186	CcSEcCtD
Pimecrolimus—Rash—Acamprosate—alcohol dependence	0.000908	0.00185	CcSEcCtD
Pimecrolimus—Dermatitis—Acamprosate—alcohol dependence	0.000907	0.00184	CcSEcCtD
Pimecrolimus—Headache—Acamprosate—alcohol dependence	0.000902	0.00183	CcSEcCtD
Pimecrolimus—Arthralgia—Citalopram—alcohol dependence	0.000901	0.00183	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000894	0.00182	CcSEcCtD
Pimecrolimus—Vomiting—Naltrexone—alcohol dependence	0.000866	0.00176	CcSEcCtD
Pimecrolimus—Oedema—Citalopram—alcohol dependence	0.000863	0.00176	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Citalopram—alcohol dependence	0.000863	0.00176	CcSEcCtD
Pimecrolimus—Rash—Naltrexone—alcohol dependence	0.000859	0.00175	CcSEcCtD
Pimecrolimus—Dermatitis—Naltrexone—alcohol dependence	0.000858	0.00175	CcSEcCtD
Pimecrolimus—Infection—Citalopram—alcohol dependence	0.000858	0.00174	CcSEcCtD
Pimecrolimus—Nausea—Acamprosate—alcohol dependence	0.000855	0.00174	CcSEcCtD
Pimecrolimus—Headache—Naltrexone—alcohol dependence	0.000854	0.00174	CcSEcCtD
Pimecrolimus—Nervous system disorder—Citalopram—alcohol dependence	0.000847	0.00172	CcSEcCtD
Pimecrolimus—Skin disorder—Citalopram—alcohol dependence	0.000839	0.00171	CcSEcCtD
Pimecrolimus—Nausea—Naltrexone—alcohol dependence	0.000809	0.00165	CcSEcCtD
Pimecrolimus—MTOR—Cellular response to heat stress—EP300—alcohol dependence	0.000803	0.00932	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000802	0.00932	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000787	0.0016	CcSEcCtD
Pimecrolimus—Paraesthesia—Citalopram—alcohol dependence	0.000775	0.00158	CcSEcCtD
Pimecrolimus—Dyspnoea—Citalopram—alcohol dependence	0.00077	0.00157	CcSEcCtD
Pimecrolimus—MTOR—BDNF signaling pathway—GRIN2B—alcohol dependence	0.000769	0.00893	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—CNR1—alcohol dependence	0.000764	0.00887	CbGpPWpGaD
Pimecrolimus—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000756	0.00878	CbGpPWpGaD
Pimecrolimus—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000745	0.00152	CcSEcCtD
Pimecrolimus—Pain—Citalopram—alcohol dependence	0.000738	0.0015	CcSEcCtD
Pimecrolimus—Constipation—Citalopram—alcohol dependence	0.000738	0.0015	CcSEcCtD
Pimecrolimus—MTOR—IFN-gamma pathway—EP300—alcohol dependence	0.000727	0.00844	CbGpPWpGaD
Pimecrolimus—Gastrointestinal pain—Citalopram—alcohol dependence	0.000706	0.00144	CcSEcCtD
Pimecrolimus—Urticaria—Citalopram—alcohol dependence	0.000686	0.00139	CcSEcCtD
Pimecrolimus—Body temperature increased—Citalopram—alcohol dependence	0.000683	0.00139	CcSEcCtD
Pimecrolimus—Abdominal pain—Citalopram—alcohol dependence	0.000683	0.00139	CcSEcCtD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000682	0.00792	CbGpPWpGaD
Pimecrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000655	0.0076	CbGpPWpGaD
Pimecrolimus—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000643	0.00747	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Citalopram—alcohol dependence	0.000636	0.00129	CcSEcCtD
Pimecrolimus—Pruritus—Citalopram—alcohol dependence	0.000611	0.00124	CcSEcCtD
Pimecrolimus—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000605	0.00702	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000598	0.00695	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Citalopram—alcohol dependence	0.000591	0.0012	CcSEcCtD
Pimecrolimus—Vomiting—Citalopram—alcohol dependence	0.000549	0.00112	CcSEcCtD
Pimecrolimus—Rash—Citalopram—alcohol dependence	0.000544	0.00111	CcSEcCtD
Pimecrolimus—Dermatitis—Citalopram—alcohol dependence	0.000544	0.00111	CcSEcCtD
Pimecrolimus—Headache—Citalopram—alcohol dependence	0.000541	0.0011	CcSEcCtD
Pimecrolimus—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000514	0.00597	CbGpPWpGaD
Pimecrolimus—Nausea—Citalopram—alcohol dependence	0.000513	0.00104	CcSEcCtD
Pimecrolimus—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000501	0.00582	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000496	0.00576	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—OPRK1—alcohol dependence	0.00044	0.0051	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000426	0.00495	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000422	0.00489	CbGpPWpGaD
Pimecrolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000416	0.00483	CbGpPWpGaD
Pimecrolimus—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00041	0.00476	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—WASF2—alcohol dependence	0.000393	0.00457	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000392	0.00455	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—WASF1—alcohol dependence	0.000377	0.00438	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000362	0.00421	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000347	0.00403	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000337	0.00391	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000318	0.00369	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—OPRD1—alcohol dependence	0.000295	0.00343	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PDYN—alcohol dependence	0.000283	0.00329	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000277	0.00322	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000266	0.00309	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000263	0.00306	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CRHR1—alcohol dependence	0.000263	0.00306	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—WASF2—alcohol dependence	0.000263	0.00306	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—GOT2—alcohol dependence	0.000261	0.00303	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—WASF1—alcohol dependence	0.000252	0.00293	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CHRM2—alcohol dependence	0.000248	0.00287	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—OPRK1—alcohol dependence	0.000247	0.00287	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—WASF2—alcohol dependence	0.000229	0.00266	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—OPRM1—alcohol dependence	0.000227	0.00264	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—GOT1—alcohol dependence	0.000225	0.00261	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000224	0.0026	CbGpPWpGaD
Pimecrolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000223	0.00259	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—WASF1—alcohol dependence	0.00022	0.00255	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NPY—alcohol dependence	0.000209	0.00243	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR1B—alcohol dependence	0.000202	0.00234	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CRH—alcohol dependence	0.000202	0.00234	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000181	0.0021	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000179	0.00208	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000177	0.00205	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—DRD4—alcohol dependence	0.000176	0.00205	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—EP300—alcohol dependence	0.00017	0.00198	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CNR1—alcohol dependence	0.000168	0.00196	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—OPRD1—alcohol dependence	0.000166	0.00193	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000164	0.00191	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—DRD2—alcohol dependence	0.000164	0.00191	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR7—alcohol dependence	0.000164	0.00191	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PDYN—alcohol dependence	0.000159	0.00185	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—WASF2—alcohol dependence	0.000148	0.00172	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CRHR1—alcohol dependence	0.000148	0.00172	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000147	0.00171	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GOT2—alcohol dependence	0.000147	0.0017	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—WASF1—alcohol dependence	0.000142	0.00165	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CHRM2—alcohol dependence	0.000139	0.00162	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—AVP—alcohol dependence	0.000138	0.00161	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—OPRM1—alcohol dependence	0.000128	0.00148	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GOT1—alcohol dependence	0.000127	0.00147	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NPY—alcohol dependence	0.000118	0.00137	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR2A—alcohol dependence	0.000115	0.00134	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR1B—alcohol dependence	0.000113	0.00132	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CRH—alcohol dependence	0.000113	0.00132	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ADH6—alcohol dependence	0.000103	0.0012	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—DRD4—alcohol dependence	9.92e-05	0.00115	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—POMC—alcohol dependence	9.59e-05	0.00111	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CNR1—alcohol dependence	9.47e-05	0.0011	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR7—alcohol dependence	9.24e-05	0.00107	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—DRD2—alcohol dependence	9.24e-05	0.00107	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—POMC—alcohol dependence	9.19e-05	0.00107	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—EP300—alcohol dependence	9.11e-05	0.00106	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—EP300—alcohol dependence	8.71e-05	0.00101	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ADH1A—alcohol dependence	8.57e-05	0.000995	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AVP—alcohol dependence	7.78e-05	0.000903	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ADH4—alcohol dependence	7.29e-05	0.000846	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR2A—alcohol dependence	6.47e-05	0.000752	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ADH7—alcohol dependence	6.2e-05	0.00072	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—EP300—alcohol dependence	6.1e-05	0.000708	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GGT2—alcohol dependence	5.94e-05	0.00069	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ADH1B—alcohol dependence	5.43e-05	0.000631	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—EP300—alcohol dependence	5.3e-05	0.000616	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—POMC—alcohol dependence	5.17e-05	0.0006	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—EP300—alcohol dependence	4.9e-05	0.000569	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—MAOB—alcohol dependence	4.5e-05	0.000523	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALDH2—alcohol dependence	3.83e-05	0.000445	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EP300—alcohol dependence	3.43e-05	0.000398	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GOT2—alcohol dependence	3.26e-05	0.000378	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP2E1—alcohol dependence	3.06e-05	0.000355	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GGT1—alcohol dependence	2.81e-05	0.000326	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GOT1—alcohol dependence	2.81e-05	0.000326	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—MAOA—alcohol dependence	2.52e-05	0.000292	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—POMC—alcohol dependence	1.64e-05	0.00019	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—EP300—alcohol dependence	1.09e-05	0.000126	CbGpPWpGaD
